Skip to main content
Premium Trial:

Request an Annual Quote

Sage-N Research Inks Deal with US Army for Proteomics-Based Pathogen Detection

Premium

Proteomics informatics firm Sage-N Research said this week it has signed an exclusive license agreement with the US Army Edgewood Chemical Biological Center to commercialize a new platform for the detection and identification of pathogenic microorganisms in fluid media.

According to Sage-N, the license allows for the ECBC's Agents of Biological Organs Identification system – which can identify 4,500 different bacteria, viruses, and fungi – to be integrated into the company's Sorcerer proteomics informatics platform.

The combination of the two platforms will facilitate the identification of microorganism via mass spec-based proteomics, enabling "identification of microorganisms down to strain level in minutes, rather than hours," ECBC senior scientist Charles Wick said in a statement.

For Sage-N, the agreement represents a push beyond the high-end proteomics research it has specialized in and into more applied markets.

"We are excited to use our core expertise to bring the power of this cutting edge technology and our Sorcerer platform to a wider audience including infectious diseases, clinical, environmental, and food testing markets," said Ali Pervez, vice president of sales and marketing at Sage-N, in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.